ACLARIS THERAPEUTICS INC shareholders Q2 2024

ACLARIS THERAPEUTICS INC's ticker is ACRS and the CUSIP is 00461U105. A total of 97 filers reported holding ACLARIS THERAPEUTICS INC in Q2 2024. The put-call ratio across all filers is 0.10 and the average weighting 0.1%.

ACLARIS THERAPEUTICS INC shareholders Q2 2024
NameSharesValueWeighting ↓
BML Capital Management, LLC 12,988,134$14,286,94710.20%
Stonepine Capital Management, LLC 1,927,446$2,120,1911.95%
Aldebaran Capital, LLC 858,152$943,9670.88%
Acuitas Investments, LLC 464,120$510,5320.27%
Trium Capital LLP 1,892,050$2,0810.26%
Aisling Capital Management LP 434,455$477,9010.21%
Samsara BioCapital, LLC 696,171$765,7880.16%
Deuterium Capital Management, LLC 72,091$79,3000.13%
Bain Capital Life Sciences Investors, LLC 1,000,000$1,100,0000.12%
Rock Springs Capital Management LP 2,753,495$3,028,8450.09%
Palo Alto Investors LP 569,832$626,8150.07%
Alpine Global Management, LLC 177,909$195,7000.03%
GSA CAPITAL PARTNERS LLP 336,677$3700.03%
Point72 Asia (Singapore) Pte. Ltd. 107,929$118,7220.02%
Marquette Asset Management, LLC 83,979$92,3770.02%
Frazier Life Sciences Management, L.P. 264,377$290,8150.01%
Y-Intercept (Hong Kong) Ltd 114,806$126,2870.01%
ACADIAN ASSET MANAGEMENT LLC 1,913,449$2,1030.01%
BBR PARTNERS, LLC 60,000$66,0000.01%
TWO SIGMA ADVISERS, LP 1,436,900$1,580,5900.00%
External links

This page lists ACLARIS THERAPEUTICS INC's shareholders in Q2 2024. To view ACLARIS THERAPEUTICS INC's shareholder history, click here.